SpringerLink
Log in

Reply to ‘Rituximab activity in CD20-positive multiple myeloma’

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bergua JM, Cabrera C, Gomez Arteta E, Prieto J . Reply to Rituximab in CD20 positive multiple myeloma. Leukemia 2008; e-pub ahead of print 1 November 2007.

  2. Gozzetti A, Fabbri A, Lazzi S, Bocchia M, Lauria F . Reply to ‘Rituximab in CD20 positive multiple myeloma’. Leukemia 2007; 21: 1842–1843.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Immunological Sciences, Division of Hematology and Transplants, University of Siena, Siena, Italy

    A Gozzetti, A Fabbri, M Bocchia & F Lauria

  2. Department of Human Pathology and Oncology, University of Siena, Siena, Italy

    S Lazzi

Authors
  1. A Gozzetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Fabbri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Lazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Bocchia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Lauria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Gozzetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gozzetti, A., Fabbri, A., Lazzi, S. et al. Reply to ‘Rituximab activity in CD20-positive multiple myeloma’. Leukemia 22, 1083 (2008). https://doi.org/10.1038/sj.leu.2405011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2405011

  • Springer Nature Limited

This article is cited by

Search

Navigation